- Do Not Prescribe (DNP), Grey
- Decision Date:
- May 2013
- Familial hypercholesterolemia: GREY 2nd line treatment option. See FH guidance for further details. (Decision date - November 2020)
- Non-familial hypercholesterolemia: GREY 2nd line alternative treatment option after atorvastatin. Can also be used when there is complete intolerance to atorvastatin or partial intolerance to other statins. See non-FH guidance for further details. (Decision date - December 2020)
Cost-effective to prescribe generically.
DO NOT PRESCRIBE (DNP): Not to be prescribed by brand - Crestor. (Decision date - August 2019)